Particularly relevant to anoikis resistance, MMP9 regulates EMT through the PI3K/AKT/NF-κB signalling pathway—a critical connection since EMT has been established as not only essential for tumour invasion but also a key feature in anoikis resistance development [56–58]. The gene discussed is PIK3CG; the disease is neoplasm.